Fibroblast Activation Protein Expressing Mesenchymal Cells Promote Glioblastoma Angiogenesis.

angiogenesis angiopoietin fibroblast activation protein glioblastoma microenvironment seprase vessel destabilisation

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
01 Jul 2021
Historique:
received: 31 05 2021
revised: 25 06 2021
accepted: 26 06 2021
entrez: 20 7 2021
pubmed: 21 7 2021
medline: 21 7 2021
Statut: epublish

Résumé

Fibroblast activation protein (FAP) is a membrane-bound protease that is upregulated in a wide range of tumours and viewed as a marker of tumour-promoting stroma. Previously, we demonstrated increased FAP expression in glioblastomas and described its localisation in cancer and stromal cells. In this study, we show that FAP

Identifiants

pubmed: 34282761
pii: cancers13133304
doi: 10.3390/cancers13133304
pmc: PMC8267680
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministerstvo Školství, Mládeže a Tělovýchovy
ID : LM2018133
Organisme : Grantová Agentura, Univerzita Karlova
ID : 1084120
Organisme : Univerzita Karlova v Praze
ID : Progres Q28/1LFUK
Organisme : Ministerstvo Školství, Mládeže a Tělovýchovy
ID : CZ.02.1.01/0.0/0.0/16_019/0000785
Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : Conceptual development of research organization 64165, General University Hospital in Prague, Czech Republic
Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : NU21-04-00100

Références

Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8219-24
pubmed: 12048246
Hepatology. 2003 May;37(5):1105-13
pubmed: 12717391
Stem Cells. 2015 Aug;33(8):2400-15
pubmed: 25966666
Lab Invest. 1996 Feb;74(2):452-66
pubmed: 8780163
Tumour Biol. 2015 Aug;36(8):5873-9
pubmed: 25712375
Nat Rev Neurol. 2018 Aug;14(8):482-495
pubmed: 29985475
J Neurooncol. 2012 Feb;106(3):493-504
pubmed: 21928115
Front Biosci (Landmark Ed). 2018 Jun 1;23:1933-1968
pubmed: 29772538
J Cell Biol. 1987 Sep;105(3):1455-62
pubmed: 3654761
Clin Exp Metastasis. 2011 Aug;28(6):567-79
pubmed: 21604185
Am J Pathol. 2006 Oct;169(4):1215-22
pubmed: 17003480
Cell Death Dis. 2013 Dec 05;4:e950
pubmed: 24309937
Peptides. 2016 Jan;75:80-95
pubmed: 26621486
Int J Biochem Cell Biol. 2012 May;44(5):738-47
pubmed: 22306301
Tumour Biol. 2016 Oct;37(10):13961-13971
pubmed: 27492457
Am J Cancer Res. 2011;1(4):482-97
pubmed: 21984967
Biol Chem. 2011 Mar;392(3):199-207
pubmed: 20707604
Acta Neuropathol Commun. 2020 Dec 11;8(1):221
pubmed: 33308315
J Neurooncol. 2015 Mar;122(1):1-10
pubmed: 25503303
Oncogene. 2018 Aug;37(32):4343-4357
pubmed: 29720723
Cell Tissue Res. 2003 Oct;314(1):15-23
pubmed: 12883993
Cancer Cell. 2010 Jan 19;17(1):98-110
pubmed: 20129251
Neurooncol Pract. 2017 Dec;4(4):201-208
pubmed: 31385993
Cell. 1996 Dec 27;87(7):1171-80
pubmed: 8980224
PLoS One. 2011;6(7):e20605
pubmed: 21754979
J Clin Oncol. 2016 May 10;34(14):1611-9
pubmed: 26976423
Cancer Cell. 2007 Jan;11(1):69-82
pubmed: 17222791
Am J Dermatopathol. 2002 Dec;24(6):473-8
pubmed: 12454598
Cancer Res. 2015 Jul 15;75(14):2800-2810
pubmed: 25979873
Int J Mol Sci. 2021 Jan 21;22(3):
pubmed: 33494271
Cancer Res. 2003 Jun 15;63(12):3403-12
pubmed: 12810677
J Neurooncol. 2006 Jan;76(1):39-48
pubmed: 16155723
Clin Transl Immunology. 2020 Oct 14;9(10):e1191
pubmed: 33082953
Sci Rep. 2018 Jun 8;8(1):8748
pubmed: 29884885
Science. 1997 Jul 11;277(5323):242-5
pubmed: 9211853
Oncol Lett. 2013 May;5(5):1615-1620
pubmed: 23760767
Int J Oncol. 2007 Oct;31(4):785-92
pubmed: 17786309
Brain Tumor Pathol. 2017 Jul;34(3):120-129
pubmed: 28646266
Mol Cancer. 2010 Jul 20;9:194
pubmed: 20646316
Angiogenesis. 2007;10(1):35-45
pubmed: 17225955
J Cell Biochem. 2020 Feb;121(2):1441-1451
pubmed: 31609020
Cell. 2013 Mar 28;153(1):139-52
pubmed: 23540695
Circ Res. 1999 Feb 19;84(3):298-305
pubmed: 10024303
J Clin Invest. 2009 Dec;119(12):3613-25
pubmed: 19920354
Science. 2010 Nov 5;330(6005):827-30
pubmed: 21051638
Antioxid Redox Signal. 2007 Sep;9(9):1363-71
pubmed: 17627476
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5618-27
pubmed: 27608497
Cancer Res. 2004 Apr 15;64(8):2712-6
pubmed: 15087384
Lancet Oncol. 2011 Oct;12(11):997-1003
pubmed: 21868284
Curr Eye Res. 2009 Feb;34(2):112-7
pubmed: 19219682
Nature. 2008 Oct 23;455(7216):1061-8
pubmed: 18772890
Cell Tissue Res. 1992 Dec;270(3):469-74
pubmed: 1283113
Cancer Cell. 2006 Mar;9(3):157-73
pubmed: 16530701
J Pathol. 2014 May;233(1):74-88
pubmed: 24481573
Lab Invest. 2006 Nov;86(11):1172-84
pubmed: 16969369
Cancer. 1996 Jan 15;77(2):362-72
pubmed: 8625246
Mol Oncol. 2016 Jan;10(1):40-58
pubmed: 26304112
J Cell Sci. 2005 Feb 15;118(Pt 4):771-80
pubmed: 15687104
Mech Dev. 2016 Aug;141:70-77
pubmed: 27178379
Hepatology. 1999 Jun;29(6):1768-78
pubmed: 10347120
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Anticancer Res. 1997 Jan-Feb;17(1A):61-9
pubmed: 9066631
J Neurooncol. 2017 Mar;132(1):35-44
pubmed: 28102487
Stat Med. 2013 Nov 30;32(27):4781-90
pubmed: 23775542
J Pathol. 2001 Mar;193(3):367-76
pubmed: 11241418
FASEB J. 2015 Jul;29(7):3076-84
pubmed: 25857554
BMC Gastroenterol. 2015 Sep 02;15:109
pubmed: 26330349
BMB Rep. 2013 May;46(5):252-7
pubmed: 23710635
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Lab Invest. 2004 Apr;84(4):397-405
pubmed: 14990981
PLoS One. 2015 Mar 16;10(3):e0116683
pubmed: 25775399

Auteurs

Eva Balaziova (E)

Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic.

Petr Vymola (P)

Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic.

Petr Hrabal (P)

Department of Pathology, Military University Hospital, 169 02 Prague, Czech Republic.

Rosana Mateu (R)

Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic.

Michal Zubal (M)

Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic.

Robert Tomas (R)

Departments of Neurosurgery, Na Homolce Hospital, 150 00 Prague, Czech Republic.

David Netuka (D)

Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital, 168 02 Prague, Czech Republic.

Filip Kramar (F)

Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital, 168 02 Prague, Czech Republic.

Zuzana Zemanova (Z)

Center of Oncocytogenomics, Institute of Clinical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic.

Karla Svobodova (K)

Center of Oncocytogenomics, Institute of Clinical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic.

Marek Brabec (M)

Institute of Computer Science, The Czech Academy of Sciences, 128 00 Prague, Czech Republic.

Aleksi Sedo (A)

Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic.

Petr Busek (P)

Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic.

Classifications MeSH